The food borne pathogen Bacillus cereus produces uronic acid-containing glycans that are secreted in a shielding biofilm environment, and certain alkaliphilic Bacillus deposit uronate-glycan polymers in the cell wall when adapting to alkaline environments. The source of these acidic sugars is unknown and, in the present study, we describe the functional identification of an operon in Bacillus cerues subsp. cytotoxis NVH 391-98 that comprises genes involved in the synthesis of UDP-uronic acids in Bacillus spp. Within the operon, a UDP-glucose 6-dehydrogenase converts UDPglucose in the presence of NAD + to UDP-glucuronic acid and NADH, and a UDP-GlcA 4-epimerase (UGlcAE) converts UDP-glucuronic acid to UDP-galacturonic acid. Interestingly, in vitro, both enzymes can utilize the TDP-sugar forms as well, albeit at lower catalytic efficiency. Unlike most of the very few bacterial 4-epimerases that have been characterized, which are promiscuous, the B. cereus UGlcAE enzyme is very specific and cannot use UDP-glucose, UDP-N-acetylglucosamine, UDP-N-acetylglucosaminuronic acid or UDP-xylose as substrates. Size exclusion chromatography suggests that UGlcAE is active as a monomer, unlike the dimeric form of plant enzymes; the Bacillus UDP-glucose 6-dehydrogenase is also found as a monomer. Phylogenic analysis further suggests that the Bacillus UGlcAE may have evolved separately from other bacterial and plant epimerases. Our results provide insight into the formation and function of uronic acidcontaining glycans in the lifecycle of B. cereus and related species containing homologous operons, as well as a basis for determining the importance of these acidic glycans. We also discuss the ability to target UGlcAE as a drug candidate.
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Introduction
Bacillus cereus has garnered much notoriety as a foodpoisoning bacterium and, similar to its close relatives, the human pathogen Bacillus anthracis and the insecticidal Bacillus thuringiensis, B. cereus has several life forms. For example, it can survive as a protective endospore in harsh conditions, in a shielding biofilm environment, or as a free-living cell in soil and water. An explanation of how changes in surface glycans confer advantages to Bacillus species during different stages of its life cycle is of great interest for understanding the pathogenesis of the organism. However, as a result of the infectious nature B. cereus and related Bacillus spp., it is understandable that many glycans have yet to be characterized, particularly those that may be made by the pathogen within the human body. Recently, polysaccharides isolated from spores of B. anthracis were shown to be antigenic and similar to cross-reactive epitopes found only in pathogenic strains of B. cereus, highlighting the role of carbohydrates in Bacillus spp. infections [1] . To identify new metabolic pathways involved in the formation of surface glycans in these pathogens, we aimed to identify putative genes encoding enzymes involved in the synthesis of glycan precursors (i.e. nucleotide sugars). These nucleotide sugars are used by specific glycosyltransferases to make the different polysaccharide structures in an organism.
The occurrence of the sugar residue galacturonic acid (GalA) in cell surface glycans varies across different bacterial species. In Gram-negative bacteria, for example, the amount and distribution of GalA in lipopolysaccharides, the major glycan molecule in the outer cell surface membrane [2] , shows significant variations. For example, the core oligosaccharide portion of the lipopolysaccharides in the symbiotic nitrogenfixing bacteria Rhizobium leguminosarum [3] and Bradyrhizobium japonicum [4] , and in the pathogen Klebsiella pneumonia [5] , consists of several GalA residues. However, the core oligosaccharides of Escherichia coli and Salmonella typhimurium lack GalA and, instead, consist of glucosamine residues. One reason for the variations in surface glycans could be that organisms form specific glycans to facilitate exclusive interactions with a particular host. Alternatively, specific glycans may display a mimicry-like structure to facilitate entry into the host, or perhaps to allow the bacteria to survive under different environmental conditions. It is also a possibility that the negative charge of acidic sugars (glycuronosyl residues) functions as an ionic barrier or to sequester metals required for normal organism function.
GalA-containing glycans have also been reported in Gram-positive bacteria. For example, GalA has been observed in the capsule of Streptococcus pneumoniae serotype 1 [6] . Interestingly, the bacterial capsular surface in S. pneumoniae was suggested to comprise the first barrier against the innate immune system, as well as being involved in mediating attachment to cells ⁄ surfaces to resist clearance. Recent analyses of B. cereus growing in biofilm have indicated that it secretes exopolysaccharides consisting of the glycuronosyl residues glucuronic acid (GlcA) and GalA [7] . GlcA and GalA residues, however, were not reported in B. cereus glycans isolated from spores or cultures grown in the laboratory [8] [9] [10] .
Synthesis of UDP-galacturonic acid (UDP-GalA) [11, 12] has been studied extensively in plants, where UDP-glucose (UDP-Glc) is first converted to UDPglucuronic acid (UDP-GlcA) by UDP-glucose 6-dehydrogenase (annotated as UGDH, UGD, UDP-GlcDH or UGlcDH). Subsequently, a very specific membranebound 4-epimerase, UDP-GlcA 4-epimerase (UGlcAE) [13, 14] interconverts UDP-GlcA and UDP-GalA. Fewer bacterial UGlcAEs have been characterized, and questions still remain concerning how the specificity for UDP-GlcA of these epimerases varies across bacterial species. Studies of the Streptococcus pneumococcus type I epimerase [15] and Gla kp from Klebsiella pneumoniae have shown that the enzymes are capable of interconverting several UDP-sugars, including UDP-GlcA, UDP-Glc and UDP-N-acetylglucosamine (GlcNAc) [5] . On the other hand, the characterization of the type I S. pneumococcus Cap1J 4-epimerase demonstrated that the enzyme had specificity for the uronic acid moiety because it was unable to interconvert UDP-Glc or UDP-Gal [16] . In the present study, we report the identification and characterization of two genes (BcUGlcDH and BcUGlcAE) involved in the biosynthesis of UDP-GlcA and UDP-GalA (Fig. 1A) from Bacillus cereus subsp. cytotoxis NVH 391-98. Interestingly, the operon for these two genes is not common in all Bacillus spp., which may provide insight into the roles of these charged-glycans within the lifecycle of this pathogen.
Results

Bioinformatic analyses of UGlcDH and UGlcAE in Bacillus
A BLAST analysis with characterized proteins from plants and bacteria was performed to identify enzymes involved in UDP-GalA production in B. cereus; and those with the greatest homology to known UGlcAE and UGlcDH were selected for further study. However, the validation of the selected enzymes based on the homology alone was challenging as a result of relative low amino-acid sequence identity with the known enzymes. For example, the potential dehydrogenase from B. cereus, Bcer98_2076, shares only 35%, 32%, 31% and 32% amino-sequence identity with functional UGlcAE from Drosophila (sugarless, UDP-Glc dehydrogenase), plants (AtUGlcDH), Cryptococcus (Ugd1) and Gram-negative Sinorizobium (rkpK, SMc02641), respectively (Fig. S1A ). In addition, the Bcer98_2076 also shares 38% sequence identity with functional GDP-mannose dehydrogenase from Pseudomonas aeruginosa [17] . Similarly, the potential epimerase from B. cereus, Bcer98_2077, shares 36% and 32% sequence identity with functional UGlcAE (AtUGlcAE3) from plants, and LpsL from Sinorizobium (SMc02640), respectively (Fig. S2B ). Having such relative low sequence identities, it is impossible to predict the function for these putative Bacillus spp. UGlcDH and UGlcAE homologs without further biochemical characterization. Interestingly, the putative dehydrogenase, Bcer98_2076, and epimerase, Bcer98_2077, from B. cereus are found in the same operon along with a putative glycosyltransferase, Bcer98_2078, that shares sequence similarity to an annotated lipopolysaccharide N-acetylglucosaminyltransferase. Similar operons (Fig. 1B) with homologous genes are found in Bacillus subtilis subsp. 168, Bacillus weihenstephanensis KBAB4, Bacillus thuringiensis serovar berliner ATCC 10792 and Geobacillus sp. G11MC16, whereas such operon organization is not found in the genomes of other Bacillaceae, such as B. anthracis strains Ames, A0248 or CDC 684. A putative nucleotidyl transferase, Bcer98_2075, is also found in proximity to the operon containing the putative dehydrogenase and epimerase, and homologous genes are found alongside the operon in B. subtilis subsp. 168, B. weihenstephanensis KBAB4, and B. thuringiensis serovar berliner ATCC 10792 but absent from Geobacillus sp. G11MC16. In B. subtilis subsp. 168, the homologous gene (ytdA BSU30850) is annotated as a putative UDP-glucose pyrophosphorylase, suggesting that Bcer98_2075 and its homologs may play a role in the synthesis of UDP-Glc (Fig. 1A) for subsequent interconversion to UDP-GlcA and UDP-GalA. To determine and elaborate upon the functions of the putative B. cereus UGlcDH and UGlcAE, we have cloned and expressed the genes as recombinant proteins in E. coli and examined their enzyme activities.
Biochemical characterization of B. cereus UGlcDH and UGlcAE
A distinct protein band migrating slightly lower than the 50 kDa standard, was detected by SDS ⁄ PAGE analysis of the extracts from E. coli cells expressing recombinant BcUGlcDH (Fig. 2A, lane 2) but was absent in E. coli cells expressing the control vector. The expressed UGlcDH protein (theoretical mass 49,792) was purified ( Fig. 2A, lane 4) and shown, The locus number for each gene in the operon across the different species shown is indicated. Based on this report, Bcer98_2076 functions as a UGlcDH and Bcer98_2077 as a UGlcAE. The operon also comprises a putative glycosyltransferase (Bcer98_2078 in B. cereus), which may be involved in the synthesis of GlcA or GalA-containing glycans. Note: except for Geobacillus sp. G11MC16, in the 5¢ region flanking the UGalA operon, there is a single gene in the opposite direction of the operon encoding a putative UDP-Glc PPase (Bcer98_2075 in B. cereus, putative ytdA in B. subtilis).
using a HPLC-based assay, to convert UDP-Glc to a new UDP-sugar (Fig. 2B , panels 2 and 4, asterisk) in the presence of NAD + and to a product that migrated as NADH (Fig. 2B , panel 4, double asterisk) with a characteristic dual UV absorption maximum at 259 and 340 nm (Fig. 2D) . The newly formed UDP-sugar eluted from the Q15 ion-exchange column with a retention time (18.8 min), comparable to UDP-GlcA standard (Fig. 2B, panel 1) . Analysis of the reaction product peak by ESI-MS operated in the negative ion mode identified an ion product (Fig. 2C, panel 1 ) of m ⁄ z 579.05, as expected for a UDP-hexuronic acid. Collision-induced ion fragmentation yielded two major ions at m ⁄ z 323.06 and 403.03 (Fig. 2C , panel 2), suggesting the formation of UMP and UDP ions, as expected. The dehydrogenase enzymatic reaction was also followed with 1 H-NMR (Fig. 3 ). As time advanced during the real-time NMR assay, a clear decrease of the peak corresponding to the anomeric proton (peak G1¢¢, 5.62 p.p.m.) of UDP-Glc was observed alongside a simultaneous increase of the peaks corresponding to the anomeric and H-5¢¢ protons of UDP-GlcA (peaks A1¢¢ and A5¢¢, 5.64 and 4.16 p.p.m., respectively). Additionally, the signal from the protons added to the NAD + nicotinamide ring after enzymatic reduction to NADH (peak H1a,b) appeared in the spectrum in the range 2.7-2.9 p.p.m. as time advanced. Peaks from other diagnostic protons of NAD + (N3, N5, N6, N7) were also diminished concomitantly with an increase of diagnostic peaks of NADH (H2, H3, H4a,b, H5, H6, H7). The ratio of the change in the diagnostic NADH proton signals compared to those of UDP-GlcA was found to be 2 : 1, validating that two moles of NAD + are reduced per mole of UDP-GlcA made in the enzymatic reaction. Hence, we named Bcer98_2076 as UDP-Glc 6-dehydrogenase (i.e. UGlcDH, or dehydrogenase).
To determine substrate specificity, other nucleotideglucose were tested. TDP-Glc was a substrate for the dehydrogenase as well, albeit with lower efficiency compared to UDP-Glc ( Table 1 ). The dehydrogenase, however, could not utilize ADP-Glc, GDP-Glc or GDP-mannose as substrates. In addition, NADP + could not substitute NAD + as the cofactor. After the reaction with TDP-Glc, the enzyme product was validated as TDP-GlcA as determined by MALDI-TOF MS in the negative mode with a major m ⁄ z ion at 577.6 and by 1 H-NMR (Fig. 4A,B) . To determine the preferred in vivo substrate of dehydrogenase, E. coli harboring the expression plasmid was grown to midlog phase and, 2 h after induction, the cells were extracted and the amount of UDP-sugar produced by E. coli determined by HPLC and ESI-MS ⁄ MS. HPLC analyses reveal a major peak at 18.3 min (comparable to the UDP-GlcA standard peak) that is absent from NDP-sugars extracted from E. coli control (data not shown). MS analyses confirm the in vivo production of UDP-GlcA as the major ion as well. Interestingly, in vitro the dehydrogenase was unable to fully convert UDP-Glc to UDP-GlcA; this was later confirmed (see below) as a result of strong inhibition of the enzyme by its product NADH.
We next proceeded to characterize the function of the second gene in the operon, Bcer98_2077. Expression of this recombinant protein in E. coli yielded a highly expressed protein migrating alongside a 37 kDa marker as expected from the theoretical mass (36 734) (Fig. 5A, lane 3 ). The enzyme was tested against various commercially available ADP-, UDP-and GDPsugars in the presence or absence of co-factors. The recombinant Bcer98_2077 converted a portion of UDP-GlcA to a new peak migrating at 22.5 min when separated on the HPLC column (Fig. 5B , panels 2 and 3, arrow). The peak was collected from the column and 1 H-NMR confirmed the enzyme product as UDPGalA because it had identical proton assignments as described previously [14] . Thus, the enzyme is a true 4-epimerase because it is capable of interconverting UDP-GalA to UDP-GlcA (not shown) as well. Hence, we named Bcer98_2077 as UDP-GlcA 4-epimerase, BcUGlcAE. Based on the sensitivity of our assay, this B. cereus 4-epimerase was unable to convert UDPglucose or UDP-xylose. The characterization of a 4-epimerase in P. aeruginosa capable of epimerizing UDP-GlcNAc and UDP-GlcNacA [18] and the recent identification of a UDP-GlcNAc 6-dehydrogenase in B. cereus subsp. cytotoxis NVH 391-98 [19] motivated us to test the epimerase with UDP-GlcNAc and UDPGlcNAcA as substrates, although no conversion was observed. However, the fact that the recombinant dehydrogenase (described above) was capable of utilizing TDP-Glc prompted us to test whether TDP-GlcA could be utilized as a substrate. Indeed, the recombinant BcUGlcAE converted a portion of TDP-GlcA to a new product as observed after separation by HPLC (Fig. 5C , panels 2 and 3, arrow). To further validate the nature of this new TDP-sugar, the peak was collected and its mass was analyzed by MALDI-TOF MS and the structure by NMR. The major mass ion at m ⁄ z 577.6 suggested a TDP-hexuronic acid (Fig. 6A ) and 1 H-NMR (Fig. 6B) confirmed the epimerase product as TDP-GalA.
Enzymatic characterization of UGlcDH and UGlcAE
The B. cereus UDP-glucose 6-dehydrogenase (BcUGlcDH) had the highest activity at a temperature of 42°C (Table S1 ). Additionally, the dehydrogenase was found to have substantial activity at high pH with its optimal pH at 9.0 in sodium phosphate buffer (Table S1 ).
Relatively little UDP-GlcA was produced in enzymatic assays conducted at pH 4 or lower. Optimal epimerase activity was observed at 55°C and, similar to the dehydrogenase, it was also most active above pH 7. Epimerase assays conducted at pH 8.2 in sodium phosphate buffer yielded the highest levels of activity. Kinetic analyses of the enzymes are summarized in 
values for the dehydrogenase were found to be 7.1 (UDP-Glc) and 21.4 (NAD + ). When TDP-Glc was used as the substrate, the apparent K m values for the dehydrogenase were 2067 lM (TDP-Glc) and 644 lM (NAD + ). The V max was found to be 19.5 pmolAEs (Tables S2 and  S3 ) have shown that the Bacillus dehydrogenase is strongly inhibited by its product NADH, whereas, on the other hand, NADH had only a marginal inhibitory effect on the epimerase activity. However, the epimerase was highly inhibited by UDP and to a lesser extent by UDP-xylose. Size-exclusion chromatography analysis of the epimerase gave an estimated molecular mass of 46.5 kDa, suggesting that the BcUGlcAE is active in a monomeric form (Table S1 ). Active dehydrogenase eluted from the size-exclusion column (Table S1 ) consistently with two distinctive peaks of activity: the first (with 20% of total activity) corresponded to a molecular mass of 152.1 kDa and the second corresponded to a molecular mass of 80.8 kDa. Considering the theoretical molecular mass of the dehydrogenase (49 kDa) and the 2 : 1 ratio of the estimated masses for the two active forms of the enzyme, size-exclusion chromatography suggested that the enzyme was most likely active as a monomer. Performing the size-exclusion chromatography of the dehydrogenase in the presence of UDP, UDP-Glc and NAD + , or only with NADH, yielded the same elution pattern (data not shown). The elution behavior of the dehydrogenase from the column is not sufficient to draw conclusion for its size. It could be function as a monomer or as a dimer and efforts to crystalize the dehydrogenase are in progress aiming to determine its form(s) in solution.
Discussion
In the present study, we have demonstrated that the food borne pathogenic bacterium B. cereus subsp. cytotoxis NVH 391-98 contains an operon that functions to generate acidic sugar-precursors (UDP-GlcA, UDP-GalA and possibly their TDP-analogs). The operon organization (Bcer98_2076, Bcer98_2077, Bcer98_2079) is conserved in few terrestrial Bacillus spp. including B. weihenstephanensis KBAB4, B. thuringiensis IBL 200, Geobacillus sp. G11MC16, and B. subtilis subsp. subtilis str. 168. Similar genes are also found in sea-dwelling bacteria such as Bacillus halodurans C-125 and others, although the operon organization varies slightly. The UGalA operon also contains a putative glycosyltransferase, which may utilize the UDP-GlcA and ⁄ or UDP-GalA as substrates for the biosynthesis of acidic sugar-containing glycans (e.g. the acidic glycan secreted by B. cereus living in biofilm). Glycans containing GlcA and GalA have been also noted in the cell walls of alkaliphilic Bacillus species B. halodurans C-125 and Oceanobacillus iheyensis. The amount of polymers containing these acidic sugars increases when such Bacillus spp. are grown in an alkaline environment. It has been demonstrated that alkaline conditions (up to pH 9) do not substantially inhibit the growth of B. cereus [20, 21] , and certain Bacillus spp., such as the deep sea-dwelling O. iheyensis, can grow at pH 10 [22] . It has been hypothesized that the presence of these acidic sugars in the outer layers of the cell wall serves to permit growth in an alkaline pH [23, 24] . The enzymatic activity of the dehydrogenase (Fig. 1A) could also help to promote survival in high pH environments because three moles protons are released per mole of UDP-GlcA formed: two protons are released to form NADH, and, at a pH of the cytosolic environment above 3.8, the carboxylic moiety of UDP-GlcA is deprotonated. Oxidation of the produced NADH could further generate free protons for the cell. An additional mechanism that may facilitate growth at high pH is the fact that a number of Bacillus spp. produce 'pectinases' and 'lyases' under alkaline conditions. Such hydrolytic enzymes are capable of hydrolyzing polygalacturonan [25] and perhaps the cell's own uronic-acid glycan. Such enzymes from B. cereus, B. subtilis and Bacillus sp. BP-23, for example, have been found to be optimally active at pH 8.5, 9.5 and 10, respectively [26, 27] . Genes for the transport and catabolism of GlcA and GalA have been identified in Bacillus spp., and the release of these free acidic sugars may help to permit Bacillus spp. growth in alkaline environments [28] . At high pH, Bacillus spp. can hydrolyze polyanionic oligosaccharide structures (i.e. GlcA-and GalA-containing glycans) and the free acidic sugars can be transported to the cell where GlcA and GalA metabolites can serve as a source of protons to acidify the cytoplasm despite the high external pH.
The balance between the oxidized and reduced forms of NAD + is assumed to reflect the metabolic activities of the cell, and the fact that the recombinant B. cereus dehydrogenase is strongly inhibited in the presence of NADH may point to the role of the UGalA operon in the B. cereus lifecycle. It is possible that the dehydrogenase serves as a checkpoint in the regulation of downstream metabolic pathways utilizing UDP-GlcA or UDP-GalA because high NADH levels will likely strongly inhibit UDP-GlcA formation and therefore also hinder UDP-GalA production in vivo. This suggests that B. cereus, in a state of abundant intracellular energy (i.e. a high NADH ⁄ NAD + ratio), may produce less GlcA and ⁄ or GalA-containing glycans. On the other hand, one function of the dehydrogenase could be to support the formation of NADH for various metabolic pathways, especially under conditions when the bacterium is deprived of essential nutrients and required to form a protective spore. This may reflect a possible role of the operon in the biosynthesis of GlcA and GalAcontaining glycans in a nutrient-starved cell (e.g. during sporulation). The intracellular concentration of NADH may act to modulate UDP-GlcA and UDP-GalA production in vegetative cells. Indeed, NADH inhibition may be a conserved feature of some UGlcDHs and has been reported in spore and nonspore forming bacteria alike. For example, NADH has been shown to inhibit a UGlcDH (TuaD BSU35580) of B. subtilis subsp. 168 that is distinct from the BcUGlcDH homolog, as well as UGlcDHs from P. aeruginosa PAO1 [29] and Cryptococcus neoformans [30] .
The enzyme specificity and the nature of their evolution are fundamental questions with respect to bacterial UGlcAE. For example, the K. pneumoniae UGlcAE can 4-epimerize UDP-GlcA, UDP-Glc and UDP-GlcNAc, whereas the Bacillus enzyme has a strict specificity for the uronic acid moiety. The Cap1J UGlcAE from S. pneumoniae has also been shown to have specificity for the uronic acid moiety, and is capable of 4-epimerizing UDP-GlcA and UDP-GalA at the same time as being unable to interconvert UDP-Glc and UDP-Gal; unfortunately, whether Cap1J can utilize UDP-GlcNAc, UDP-GlcNAcA or other nucleotide sugars has not been tested [16] . We have tried to address the promiscuity of some 4-epimerases by analyzing the origin of UGlcAE proteins (from the known UGlcAE and homologs that share high amino acid sequence identity). Phylogenic analysis of eukaryotic and bacterial UGlcAE clearly separates the Bacillus spp. UGlcAE into a separate and distinct clade (Fig. S2A) . Although plant and promiscuous bacterial UGlcAE are related (e.g. AtUGlcAE2, Cap1J and Gla kp ), the Bacillus spp. appear to belong to a different group that is well separated from other bacterial and eukaryotic UGlcAE. The phylogeny suggests that UGlcAE enzymes might share the same ancestor because those enzymes are well divided from UDPglucose-4-epimerases (UGEs) and decarboxylases. However, currently we cannot predict the evolution of Bacillus UGlcAE.
The ability of the Bacillus dehydrogenase and epimerase to utilize TDP-Glc and TDP-GlcA, respectively, may point to a separate or additional role of the operon in the B. cereus life cycle. TDP-Glc is a product formed in B. anthracis for the synthesis of TDP-rhamnose (Rha) [31] , and homologous proteins for TDPRha production are also found in the B. cereus genome [32] . In B. anthracis, Rha residues are incorporated into the spore glycoprotein bclA, and Rha residues have been shown to be major components of the glycans in the exosporium of B. cereus [33] . Rha is also a minor constituent of the biofilm exo-polysaccharides of B. cereus [7] . However, the capability of the enzymes to interconvert TDP-Glc and TDP-GlcA may be the result of the structural similarity between the thymine and uracil moieties of the TDP-and UDP-sugars.
At present, the function of glucuronic and galacturonic acid at different points of the B. cereus lifecycle remains to be determined, and the identification of the UGalA operon will help to allow the elucidation of their importance. Our laboratory is unfortunately not licensed to work with this human pathogen, as is necessary for genetic deletion of the operon; however, gene knockouts in nonpathogenic Bacillus spp. also possessing the UGalA operon (Fig. 1B) could be used to reveal its role. Efforts are underway to examine the function of these genes and perhaps their utilization in adapting to high pH in different Bacillus spp. Determination of the expression of the genes of the UGalA operon in response to various environment stimuli (e.g. alkaline pH, nutrient limitation or temperature extremes) may also be advantageous in developing an understanding of the biological role of the operon.
If the GalA-containing glycans are shown to be necessary for survival of the organism, the Bacillus UGlcAE may prove to be a potential target for drugs combating this pathogen. As far as we are aware, humans do not synthesize GalA-containing glycans and are not considered to possess UGlcAEs. Indeed, the specificity of the Bacillus enzyme may permit the development of inhibitors restricted to BcUGlcAE that do not affect similar enzymes necessary for normal human metabolism.
Materials and methods
Cloning of BcUGlcDH and BcUGlcAE
The Bcer98_2076 and Bcer98_2077 genes from Bacillus cereus subsp. cytotoxis NVH 391-98, herein named, UDP-Glc 6-dehydrogenase (BcUGlcDH) and UDP-glucuronic acid 4-epimerase (BcUGlcAE), respectively, were cloned by high-fidelity PCR from genomic DNA. PCR primers were: sense 5¢-Ccatggtgaatatatgcattataggatctg-3¢ and antisense 5¢-AAGCTTtgagcgaccaactcctacatagc-3¢ for BcUGlcDH; and sense 5¢-Tcatgaaaatacttgttactggagcag-3¢ and antisense 5¢-AAGCTTatataattgcttcatatactc-3¢ for BcUGlcAE. Genomic DNA was kindly provided by the laboratory of A. Sorokin (Ge´ne´tique Microbienne, INRA, France). The agarose gel-purified PCR fragments were cloned to yield the plasmids: pCR4-gmdh#2 and pCR4-gmad#1, respectively. The corresponding DNA sequences were deposited in Genbank (with respective accession numbers HM581980 and HM581979). The Nco1-HindIII fragment of BcUGlcDH (1289 bp) and BspH1-HindIII fragment of BcUGlcAE (944 bp) were cloned into an E. coli expression vector to form pET28b:BcUGlcDH#1 and pET28b:BcUGlcAE#1, respectively. The recombinant enzymes were designed to have a six-histidine extension at their C-terminus to facilitate affinity-purification.
Expression and purification of recombinant proteins
E. coli cells harboring pET28b:BcUGlcAE#1 or a control vector (pET28) were cultured for 16 h at 37°C (or 30°C for pET28b:BcUGlcDH#1 or a control vector) in 20 mL of LB medium supplemented with kanamycin (50 lgAEmL was eluted with the same buffer containing an increased amount of imidazole (0-250 mM). Similarly, the bound BcUGlcDH-6His was eluted from Ni-column with solution adjusted to pH 8, which was composed of 0.3 M NaCl, 50 mM sodium phosphate and imidazole (0-250 mM). The fraction containing BcUGlcAE activity, typically eluted with 250 mM imidazole, was supplemented with 1 mM dithiothreitol and 10% glycerol, and was dialyzed (6000-8000 molecular weight cut-off; Spectrum Laboratories, Inc., Rancho Dominguez, CA, USA) three times (twice for 30 min, and once for 1 h), each time against 800 mL of cold dialysis buffer [50 mM sodium phosphate, pH 7.6, containing 0.1 M NaCl, 10% (v ⁄ v) glycerol, 1 mM dithiothreitol]. The protein after dialysis was divided into small aliquots, flash frozen in liquid nitrogen and stored at -80°C. The Ni-column fraction containing UDP-GlcDH activity, typically eluted with 250 mM imidazole, was supplemented with 20% glycerol, divided into aliquots, flash frozen and kept at )80°C. Proteins extracted from E. coli cells expressing the control vector were obtained using the same purification protocol and were used as controls in enzyme assays and SDS ⁄ PAGE analyses. Proteins concentration was determined using the Bradford reagent with BSA as standard. The native molecular weight of the dehydrogenase and the epimerase was estimated by size-exclusion chromatography using a Superdex-75 column (GE Healthcare) as described previously [34] .
UGlcDH and UGlcAE enzyme assays, HPLC and product analyses by NMR 
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